Ligand validation:3K4M

FAD: FLAVIN-ADENINE DINUCLEOTIDE

FAD is a Ligand Of Interest in 3K4M designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3K4M_FAD_E_801	61%	21%	0.172	0.962	1.13	2.15	3	18	9	1	100%	1
3K4M_FAD_D_801	61%	12%	0.182	0.971	1.22	2.83	2	28	6	0	100%	1
3K4M_FAD_C_801	59%	14%	0.181	0.965	1.35	2.49	6	22	4	2	100%	1
3K4M_FAD_F_801	58%	17%	0.188	0.969	1.42	2.13	9	22	1	2	100%	1
3K4M_FAD_A_801	58%	13%	0.192	0.971	1.34	2.62	9	22	2	1	100%	1
3K4M_FAD_G_801	55%	18%	0.196	0.965	1.3	2.22	6	20	3	0	100%	1
3K4M_FAD_B_801	54%	18%	0.198	0.964	1.29	2.2	4	22	5	1	100%	1
3K4M_FAD_H_801	54%	7%	0.203	0.968	1.22	3.47	6	29	3	2	100%	1
2IGK_FAD_B_801	100%	24%	0.038	0.987	1.43	1.65	8	12	8	0	100%	1
3FDY_FAD_A_801	100%	20%	0.046	0.988	1.35	2.01	5	20	0	0	100%	1
2IGM_FAD_B_801	99%	10%	0.055	0.985	1.37	2.92	7	20	13	0	100%	1
3K4L_FAD_A_801	98%	21%	0.059	0.984	1.41	1.87	9	19	5	0	100%	1
3PL8_FAD_A_801	98%	36%	0.065	0.99	1.35	1.17	8	4	1	0	100%	1
2R4J_FAD_B_600	100%	13%	0.024	0.995	2	1.99	18	19	0	0	100%	1
3IC9_FAD_B_490	100%	32%	0.025	0.996	1.23	1.45	7	8	0	0	100%	1
2IPI_FAD_C_801	100%	14%	0.026	0.994	1.79	2.09	14	23	9	0	100%	1
4KGD_FAD_B_701	100%	45%	0.031	0.997	1.1	1.03	2	2	0	0	100%	1
4PVH_FAD_A_601	100%	35%	0.028	0.993	1.32	1.23	7	7	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.